Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,800 | -24,961 | -13,144 | -12,047 | -11,434 |
| Depreciation Amortization | 333 | 366 | 74 | 70 | 123 |
| Accounts receivable | N/A | N/A | N/A | N/A | 216 |
| Other Working Capital | 157 | -1,353 | 3,012 | 140 | 1,687 |
| Other Operating Activity | -164 | 10,948 | 862 | 350 | -15 |
| Operating Cash Flow | $-16,474 | $-15,001 | $-9,197 | $-11,487 | $-9,423 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 1,611 | -21 |
| PPE Investments | -22 | -8 | -83 | -82 | -18 |
| Investing Cash Flow | $-22 | $-8 | $-83 | $1,530 | $-39 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,266 | 10,047 | 7,862 | 7,996 | N/A |
| Other Financing Activity | 28,425 | 5,791 | 2,399 | 1,887 | 722 |
| Financing Cash Flow | $29,691 | $15,837 | $10,260 | $9,884 | $722 |
| Exchange Rate Effect | -451 | -490 | 457 | -79 | -309 |
| Beginning Cash Position | 10,562 | 10,324 | 9,132 | 9,283 | 18,137 |
| End Cash Position | 23,305 | 10,662 | 10,570 | 9,130 | 9,088 |
| Net Cash Flow | $12,744 | $338 | $1,438 | $-153 | $-9,049 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,474 | -15,001 | -9,197 | -11,487 | -9,423 |
| Capital Expenditure | -22 | -8 | -83 | -82 | -18 |
| Free Cash Flow | -16,496 | -15,010 | -9,279 | -11,569 | -9,441 |